---
layout: default
title: ProstNFound+: A Prospective Study using Medical Foundation Models for Prostate Cancer Detection
---

# ProstNFound+: A Prospective Study using Medical Foundation Models for Prostate Cancer Detection

**arXiv**: [2510.26703v1](https://arxiv.org/abs/2510.26703) | [PDF](https://arxiv.org/pdf/2510.26703.pdf)

**ä½œè€…**: Paul F. R. Wilson, Mohamed Harmanani, Minh Nguyen Nhat To, Amoon Jamzad, Tarek Elghareb, Zhuoxin Guo, Adam Kinnaird, Brian Wodlinger, Purang Abolmaesumi, Parvin Mousavi

---

## ðŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºProstNFound+ä»¥è§£å†³å‰åˆ—è…ºç™Œå¾®è¶…å£°æ£€æµ‹çš„ä¸´åºŠéªŒè¯é—®é¢˜**

**å…³é”®è¯**: `å‰åˆ—è…ºç™Œæ£€æµ‹` `åŒ»å­¦åŸºç¡€æ¨¡åž‹` `å¾®è¶…å£°æˆåƒ` `é€‚é…å™¨è°ƒä¼˜` `å‰çž»æ€§éªŒè¯` `ç™Œç—‡çƒ­å›¾`

## ðŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. æ ¸å¿ƒé—®é¢˜ï¼šåŒ»å­¦åŸºç¡€æ¨¡åž‹åœ¨å‰åˆ—è…ºç™Œå¾®è¶…å£°æ£€æµ‹ä¸­çš„ä¸´åºŠåº”ç”¨æœªç»éªŒè¯
2. æ–¹æ³•è¦ç‚¹ï¼šç»“åˆåŒ»å­¦åŸºç¡€æ¨¡åž‹ã€é€‚é…å™¨è°ƒä¼˜å’Œä¸´åºŠç”Ÿç‰©æ ‡å¿—ç‰©æç¤ºç¼–ç 
3. å®žéªŒæˆ–æ•ˆæžœï¼šå‰çž»æ€§éªŒè¯æ˜¾ç¤ºå¼ºæ³›åŒ–èƒ½åŠ›ï¼Œä¸Žä¸´åºŠè¯„åˆ†ä¸€è‡´

## ðŸ“„ æ‘˜è¦ï¼ˆåŽŸæ–‡ï¼‰

> Purpose: Medical foundation models (FMs) offer a path to build
> high-performance diagnostic systems. However, their application to prostate
> cancer (PCa) detection from micro-ultrasound ({\mu}US) remains untested in
> clinical settings. We present ProstNFound+, an adaptation of FMs for PCa
> detection from {\mu}US, along with its first prospective validation. Methods:
> ProstNFound+ incorporates a medical FM, adapter tuning, and a custom prompt
> encoder that embeds PCa-specific clinical biomarkers. The model generates a
> cancer heatmap and a risk score for clinically significant PCa. Following
> training on multi-center retrospective data, the model is prospectively
> evaluated on data acquired five years later from a new clinical site. Model
> predictions are benchmarked against standard clinical scoring protocols
> (PRI-MUS and PI-RADS). Results: ProstNFound+ shows strong generalization to the
> prospective data, with no performance degradation compared to retrospective
> evaluation. It aligns closely with clinical scores and produces interpretable
> heatmaps consistent with biopsy-confirmed lesions. Conclusion: The results
> highlight its potential for clinical deployment, offering a scalable and
> interpretable alternative to expert-driven protocols.

